Latest filing published 09 Mar 2021 for Fate Therapeutics INC, €217k.
Filing timeline
BuySaleInsider track record
Daniel D. Shoemaker: trading record in brief
Daniel D. Shoemaker discloses dealings in Fate Therapeutics Inc to SEC (Form 4). Over a trading history stretching from 31 March 2014 to 8 March 2021, the count stands at 40 filings.
No open-market purchase appears, only 31 sales worth €5.7M. Besides market trades, the filings include 6 share grants and 3 option exercises. 2021 to date brings no purchases and 15 sales.
The newest entry dates from 9 March 2021: an open-market sale of €58k, in Fate Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel D. Shoemaker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,298 shares@ US$78.60Common stockSEC:0001209191-21-018932:0
- 4,627 shares@ US$79.58Common stockSEC:0001209191-21-018932:1
- 5,174 shares@ US$80.73Common stockSEC:0001209191-21-018932:2
- 2,993 shares@ US$81.60Common stockSEC:0001209191-21-018932:3
- 2,480 shares@ US$83.46Common stockSEC:0001209191-21-018932:4
- 2,728 shares@ US$84.20Common stockSEC:0001209191-21-018932:5
- 2,900 shares@ US$85.50Common stockSEC:0001209191-21-018932:6
- 800 shares@ US$86.70Common stockSEC:0001209191-21-018932:7
- 14,411 shares0Common stockSEC:0001209191-21-004954:0
- 2,755 shares@ US$117.60Common stockSEC:0001209191-21-003338:0
- 2,451 shares@ US$117.15Common stockSEC:0001209191-21-003338:1
- 872 shares@ US$115.80Common stockSEC:0001209191-21-003338:2
- 151 shares@ US$114.760.0% of flowCommon stockSEC:0001209191-21-003338:3
- 1,332 shares@ US$111.62Common stockSEC:0001209191-21-003338:4
- 1,050 shares@ US$110.76Common stockSEC:0001209191-21-003338:5
- 871 shares@ US$109.65Common stockSEC:0001209191-21-003338:6
- 4,932 shares@ US$50.3663Common stockSEC:0001209191-20-058492:0
- 5,287 shares@ US$51.603Common stockSEC:0001209191-20-058492:1
- 14,781 shares@ US$52.3993Common stockSEC:0001209191-20-058492:2
- 1,400 shares@ US$35.402.7% of flowCommon stockSEC:0001209191-20-050681:0
- 17,887 shares@ US$36.1135.7% of flowCommon stockSEC:0001209191-20-050681:1
- 5,713 shares@ US$37.1211.7% of flowCommon stockSEC:0001209191-20-050681:2
- 25,000 shares0Common StockSEC:0001209191-20-003025:0
- 5,700 shares@ US$20.705.3% of flowCommon StockSEC:0001209191-20-003025:1
- 25,000 shares@ US$2.903.2% of flowCommon StockSEC:0001209191-20-000242:0
25 of 40 declarations
